AR084530A2 - Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados - Google Patents

Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados

Info

Publication number
AR084530A2
AR084530A2 ARP110104871A AR084530A2 AR 084530 A2 AR084530 A2 AR 084530A2 AR P110104871 A ARP110104871 A AR P110104871A AR 084530 A2 AR084530 A2 AR 084530A2
Authority
AR
Argentina
Prior art keywords
virus
prrsv
facilitate
production
respiratory syndrome
Prior art date
Application number
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR084530A2 publication Critical patent/AR084530A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Un método para facilitar la producción del Virus del Síndrome Reproductor y Respiratorio Porcino (PRRSV) a partir de un cultivo de células de vertebrados que comprende los pasos de: (a) proveer una célula recombinante de vertebrados transfectada con un polinucleótido exógeno que codifica un polipéptido que tiene un dominio de transmembrana y al menos 85% de identidad de secuencia con la SEQ ID Nº 2, tal que la expresión del polipéptido en dicha célula se incrementa; (b) poner en contacto un cultivo de dicha célula con virus PRRSV bajo condiciones que permiten la infección de las células y el crecimiento del virus; y (c) recuperar el virus de dicho cultivo.
ARP110104871 2004-04-23 2011-12-21 Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados AR084530A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09

Publications (1)

Publication Number Publication Date
AR084530A2 true AR084530A2 (es) 2013-05-22

Family

ID=35320736

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP050101615 AR049033A1 (es) 2004-04-23 2005-04-22 Factor de permisividad celular para virus y usos del mismo
ARP110104870 AR084529A2 (es) 2004-04-23 2011-12-21 Un metodo para la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados
ARP110104871 AR084530A2 (es) 2004-04-23 2011-12-21 Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP050101615 AR049033A1 (es) 2004-04-23 2005-04-22 Factor de permisividad celular para virus y usos del mismo
ARP110104870 AR084529A2 (es) 2004-04-23 2011-12-21 Un metodo para la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados

Country Status (21)

Country Link
US (4) US7754464B2 (es)
EP (2) EP2520310B1 (es)
JP (2) JP5273642B2 (es)
CN (1) CN102220289B (es)
AR (3) AR049033A1 (es)
AU (2) AU2005240002B2 (es)
BR (1) BRPI0508928B1 (es)
CA (1) CA2564769C (es)
CL (1) CL2008002323A1 (es)
DK (1) DK1742658T3 (es)
EA (1) EA013071B1 (es)
ES (2) ES2530694T3 (es)
IL (1) IL178160A0 (es)
MA (1) MA28544B1 (es)
MX (1) MXPA06012216A (es)
NO (1) NO341211B1 (es)
NZ (1) NZ550145A (es)
PL (1) PL1742658T3 (es)
TW (2) TWI438278B (es)
UY (1) UY28867A1 (es)
WO (1) WO2005107796A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2564769C (en) * 2004-04-23 2013-12-17 Pharmacia & Upjohn Company Llc Cellular permissivity factor for viruses, and uses thereof
US8202717B2 (en) * 2007-01-12 2012-06-19 The Board Of Trustees Of The University Of Illinois Non-simian cells for growth of porcine reproductive and respiratory syndrome (PRRS) virus
AU2008290914A1 (en) * 2007-07-27 2009-02-26 Universiteit Gent Permissive cells and uses thereof
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
CA2872789C (en) 2012-05-17 2019-09-03 Zoetis Llc Effective vaccination against porcine reproductive and respiratory syndrome (prrs) virus prior to weaning
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
CN110072547B (zh) 2016-12-14 2024-04-30 硕腾服务有限责任公司 断奶前对抗欧洲猪繁殖与呼吸综合征(prrs)病毒株的有效疫苗接种
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
WO2024123640A1 (en) 2022-12-06 2024-06-13 Zoetis Services Llc Methods and compositions for vaccinating piglets against prrs-1 virus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
ES2151463T5 (es) 1989-12-22 2012-10-29 Merck Serono Sa Constructos de ADN para la activación y la modificación de la expresión de genes endógenos
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
AU664847B2 (en) 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
US6740490B2 (en) 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
WO2003010200A2 (en) 2001-07-24 2003-02-06 Akzo Nobel, N.V. Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
AU2003243058A1 (en) * 2002-05-27 2003-12-12 Bioceros B.V. Methods for using the cd163 pathway for modulating an immune response
CA2564769C (en) * 2004-04-23 2013-12-17 Pharmacia & Upjohn Company Llc Cellular permissivity factor for viruses, and uses thereof

Also Published As

Publication number Publication date
IL178160A0 (en) 2006-12-31
NO341211B1 (no) 2017-09-11
ES2530694T3 (es) 2015-03-04
WO2005107796A2 (en) 2005-11-17
AR049033A1 (es) 2006-06-21
WO2005107796A3 (en) 2007-04-12
CN102220289A (zh) 2011-10-19
US20120015425A1 (en) 2012-01-19
MA28544B1 (fr) 2007-04-03
JP5600340B2 (ja) 2014-10-01
US20140141492A1 (en) 2014-05-22
EP1742658B1 (en) 2014-12-24
TWI438278B (zh) 2014-05-21
CL2008002323A1 (es) 2008-12-19
EP2520310A1 (en) 2012-11-07
JP2013078324A (ja) 2013-05-02
CA2564769A1 (en) 2005-11-17
EP2520310B1 (en) 2016-03-30
BRPI0508928B1 (pt) 2015-10-06
CA2564769C (en) 2013-12-17
US8486685B2 (en) 2013-07-16
AR084529A2 (es) 2013-05-22
AU2005240002B2 (en) 2009-06-18
US20050271685A1 (en) 2005-12-08
JP5273642B2 (ja) 2013-08-28
US20100273238A1 (en) 2010-10-28
NO20065115L (no) 2006-11-06
ES2570665T3 (es) 2016-05-19
MXPA06012216A (es) 2007-01-17
JP2007533321A (ja) 2007-11-22
AU2005240002A1 (en) 2005-11-17
NZ550145A (en) 2009-07-31
EP1742658A2 (en) 2007-01-17
HK1109065A1 (en) 2008-05-30
AU2009202410A1 (en) 2009-07-09
DK1742658T3 (en) 2015-01-19
TWI354025B (en) 2011-12-11
US9102912B2 (en) 2015-08-11
CN102220289B (zh) 2014-05-21
TW200604343A (en) 2006-02-01
EA200601677A1 (ru) 2007-10-26
EA013071B1 (ru) 2010-02-26
EP1742658A4 (en) 2007-11-28
US7754464B2 (en) 2010-07-13
US8058050B2 (en) 2011-11-15
UY28867A1 (es) 2005-11-30
BRPI0508928A (pt) 2007-08-14
TW201134944A (en) 2011-10-16
PL1742658T3 (pl) 2015-05-29

Similar Documents

Publication Publication Date Title
AR084530A2 (es) Un metodo para facilitar la produccion del virus del sindrome reproductor y respiratorio porcino (prrsv) a partir de un cultivo de celulas de vertebrados
Wang et al. A novel decellularized matrix of Wnt signaling-activated osteocytes accelerates the repair of critical-sized parietal bone defects with osteoclastogenesis, angiogenesis, and neurogenesis
ES2533874T3 (es) Armazón proteico
MX2020013236A (es) Acido ribonucleico (arn) circular para traduccion en celulas eucariotas.
AR077022A1 (es) Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para variar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
RU2010108308A (ru) Способ получения гетерогенных белков
EA201270173A1 (ru) Получение полиовируса с высокими титрами для получения вакцины
AR037415A1 (es) Metodo para producir l-aminoacidos utilizando bacterias que pertenecen al genero escherichia
ATE415478T1 (de) Fermentationsverfahren zur herstellung von l- aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
ES2689932T3 (es) Construcciones de armazones de células
ATE286995T1 (de) Elektrolysezelle, insbesondere zur elektrochemischen herstellung von chlor
AR086932A2 (es) Metodo para la produccion de polipeptidos
PE20110358A1 (es) Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias
TR200200897T2 (tr) Melez matrisler ve melez matriks karışımları
CO5580165A1 (es) Vacunas de rotavirus modificado
CO6491059A2 (es) Diferenciacion de las celulas madre mesenquimales
ES2169225T3 (es) Micro-organismo tolerante del estres y procedimiento de produccion de producto de fermentacion.
AR039460A1 (es) Factores camp quimericos
AR069892A1 (es) Furina recombinante libre de proteinas sustancialmente animal y metodos para producirla. composicion.
AR086200A1 (es) Hongos filamentosos que tienen un fenotipo de viscosidad alterado
MX2022006534A (es) Daao modificada y el uso de la misma.
CL2008003821A1 (es) Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado
MX2021013728A (es) Ibv atenuado con tropismo de cultivo celular y tisular extendido.
CL2009001249A1 (es) Uso de una enzima pectonilitica endopoligalacturonasa para tratar pure de frutas o verduras; procedimiento para tratamiento enzimatico; molecula de adn que codifica un polipeptido con actividad endopoligalacturonasa; polipeptido, vector de expresion y celula huesped que comprende dicha secuencia.
AR064252A1 (es) Plantas que presentan caracteristicas acrecentadas relacionadas con el rendimiento y un metodo para producir las mismas

Legal Events

Date Code Title Description
FB Suspension of granting procedure